Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-20-054825

EVP, CBO, GC & Secretary sold 39,271 shares at an average $16.86 ($661,969)

  • EVP, CBO, GC & Secretary acquired 39,271 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Primiano Christopher Brett · EVP, CBO, GC & Secretary

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2020-10-13 Exercise or conversion : show line 1 in the form +38,550 $9.21 $355,046 43,199 D
2020-10-13 Sale : show line 2 in the form −38,550 $16.85 $649,568 4,649 D
2020-10-13 Exercise or conversion : show line 3 in the form +721 $10.39 $7,491 5,370 D
2020-10-13 Sale : show line 4 in the form −721 $17.20 $12,401 4,649 D
Open-market sales · 39,271 sh · avg $16.86 · $661,969

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-10-13 Exercise or conversion : show line 5 in the form Stock Option (right to buy) −38,550 $9.21 2029-02-14 38,550 64,250 D
2020-10-13 Exercise or conversion : show line 6 in the form Stock Option (right to buy) −721 $10.39 2027-01-19 721 75,779 D
Loading xslF345X03/doc4.xml…